lead - search results

Here, we learn about a British company launching a fast-acting antimicrobial coating that destroys coronavirus.

Here Nikolas Kairinos, Founder and CEO of Soffos, delves into the difficult subject of diversity standards in the AI space.

Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces ImotopesTM a cutting-edge immunotherapy science with an excellent safety profile that could cure Type 1 diabetes or drastically change treatment options.

Sal Murdoch, Marketing Director at Fiscal Technologies, discusses how AI can be used to simplify complexity and deliver clarity across public sector procure-to-pay.

Here, Alberto Troccoli explains why and how Europe’s H2020 project SECLI-FIRM continues to offer accurate seasonal climate forecasting which can reduce risk and cost alike for energy and water businesses.

Timothy Kwok, Professor at The Chinese University of Hong Kong, tells us about the Electronic Cognitive Screen (EC-Screen) that gives a brief and user-friendly digital cognitive test for the detection of dementia in older people.

Kate Edwards, Director of LumiBio, highlights what we need to know about COVID-19 infection, prevention and control (IPC)

Sarah Coolican, Project Coordinator, explains how the new Racism and International Politics programme at LSE IDEAS hopes to facilitate urgent, ongoing conversations of global racial disparity.

CBD oil has long been utilised for its various therapeutic effects, but what about its effect on cancer? Read on to find out more about what the research shows.

Jonas J. Calsbeek, Jeremy A. MacMahon & Pamela J. Lein, PhD from University of California, Davis, explain the emerging science of tattoo toxicology.

Bertrand Lebouché, MD, PhD is a HIV and HCV Primary Care specialist at the Chronic Viral Illness Service of the McGill University Health Centre (MUHC) An Associate Professor of Family Medicine at McGill University (Montreal, Canada), and a scientist conducting patient-oriented clinical research in HIV. Dr. Lebouché completed his medical...

Phillip P. Chan, MD, PhD, Chief Executive Officer of CytoSorbents Corporation (NASDAQ: CTSO), discusses the use of CytoSorb, a broad-spectrum blood purification technology to treat cytokine storm and hyperinflammation in critically ill COVID-19 patients.

Megan Warrender, Assistant Editor at Open Access Government, investigates the current and future policy priorities of the Commissioner for the Environment, Oceans and Fisheries, Virginijus Sinkevičius, and what is influencing them.

Marco Landi, President of Council of European Dentists, considers dentistry during the COVID-19 pandemic and the extent to which oral health is still a priority.

Darrel Baumgardner, Chief Scientist at Droplet Measurement Technologies LLC asks if cloud seeding can partially mitigate the environmental impact of climate change, in this the first part of a series of special articles, starting with some basic principles.

Frank F Vincenzi, Professor Emeritus, University of Washington, tells us about the mammalian dive response (MDR), drawing on the case of the woman who developed a fatal heart rhythm while SCUBA diving.

Ken Saito, Associate Professor from College of Science and Technology, Nihon University in Japan, tell us about a millimetre-sized microrobot with an artificial brain.

Professor Achim Stahl at RWTH Aachen University discusses technological challenges and innovation in gravitational wave science, with a detailed look at Einstein Telescope.

The independent experts of the FDA say the Pfizer vaccine is good to go, which means that the COVID vaccine should be formally approved in a matter of days.

Stephen Skinner, Professor of Materials Chemistry at Imperial College London, explores the possible routes available to produce clean hydrogen and ensure a low carbon future.